Atlas Trials

Impact of Immune Checkpoint Inhibitor Therapy on Type 2 Inflammation

Clinical trial NCT04609930 · COMPLETED

Trial details

NCT number
NCT04609930
Sponsor
University Hospital, Montpellier
Status
COMPLETED
Study type
OBSERVATIONAL
Patients Recieving Anti-PD-1 or Anti-PD-L1 Immunotherapies
Start date
2020-10-30
Primary completion
2021-08-31
Enrollment
143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.